Long term persistence
Showing 1 - 25 of >10,000
Manualized MDMA-Assisted Therapy for Treatment of Posttraumatic
Enrolling by invitation
- PTSD
-
San Francisco, CaliforniaUSCF
Jan 23, 2023
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
Coronavirus Disease 2019 Trial in Buenos Aires (serology)
Completed
- Coronavirus Disease 2019
- serology
-
Buenos Aires, Ciudad De Buenos Aires, ArgentinaHospital de Niños Ricardo Gutierrez
Aug 23, 2021
Survival of Genetically Modified White Blood Cells in
Active, not recruiting
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 3, 2023
Vaccine Trial in Jakarta (Vi-DT Typhoid Conjugate Vaccine)
Recruiting
- Vaccine
- Vi-DT Typhoid Conjugate Vaccine
-
Jakarta, Indonesia
- +1 more
Jul 16, 2021
Virus Diseases Trial in Hradec Kralove (Encepur Adults)
Completed
- Virus Diseases
- Encepur Adults
-
Hradec Kralove, CzechiaGSK Investigational Site
Jul 4, 2022
Chikungunya Virus Infection Trial in United States (VLA1553)
Enrolling by invitation
- Chikungunya Virus Infection
- VLA1553
-
Phoenix, Arizona
- +10 more
Oct 21, 2021
Poliomyelitis, Vaccine Reaction Trial (Eupolio)
Not yet recruiting
- Poliomyelitis
- Vaccine Reaction
- Eupolio
- (no location specified)
Jun 23, 2022
Dengue Fever Trial in Mexico, United States (Tetravalent Dengue Vaccine (TDV), Placebo)
Active, not recruiting
- Dengue Fever
- Tetravalent Dengue Vaccine (TDV)
- Placebo
-
Huntsville, Alabama
- +9 more
Nov 15, 2021
Herpes Zoster Trial in Tartu (HZ/su vaccine)
Recruiting
- Herpes Zoster
- HZ/su vaccine
-
Elkridge, Maryland
- +47 more
Jan 6, 2023
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Infections, Cytomegalovirus Trial in La Louvière, Wilrijk (Blood sampling, GSK149203A)
Completed
- Infections, Cytomegalovirus
- Blood sampling
- GSK149203A
-
La Louvière, Belgium
- +1 more
Dec 18, 2019
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Poland (GSK1024805A, Prevenar, Infanrix hexa)
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- GSK1024805A
- +4 more
-
Bydgoszcz, Poland
- +5 more
Jan 11, 2021
Participants Previously Treated With Century Therapeutics
Not yet recruiting
- Hematological Malignancy
- Solid Tumor Malignancy
- No Intervention
- (no location specified)
Mar 3, 2023
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Not yet recruiting
- Non Hodgkin Lymphoma
- Long-term Follow-Up
-
Stanford, California
- +4 more
Oct 30, 2023
Hypertension, Blood Pressure Trial in Kladno (Long-term non-invasive Blood pressure monitoring)
Enrolling by invitation
- Hypertension
- Blood Pressure
- Long-term non-invasive Blood pressure monitoring
-
Kladno, CzechiaCzech Technical University in Prague
Oct 18, 2023
Long Term Impact of COVID-19
Active, not recruiting
- Long COVID-19
- +2 more
- Observational patient reported outcomes
-
Enschede, Overijssel, NetherlandsMedisch Spectrum Twente
Apr 14, 2023
Long-Term Post Thrombotic Syndrome Assessment.
Recruiting
- Post Thrombotic Syndrome
- Phone call
-
Grenoble, FranceROLLAND
Sep 19, 2023
Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules)
Recruiting
- Schizophrenia
- Xanomeline and Trospium Chloride Capsules
-
Atlanta, Georgia
- +4 more
Jan 5, 2023
Epilepsy Trial (UNEEG EpiSight solution)
Not yet recruiting
- Epilepsy
- UNEEG EpiSight solution
- (no location specified)
Jun 22, 2023
After Removal of Rib Stabilization Hardware in Blunt Chest
Not yet recruiting
- Rib Fractures
- data collection on patient reported long-term outcome of SSRF hardware removal
-
Basel, SwitzerlandDepartment of Thoracic Surgery, University Hospital Basel
Aug 14, 2023
Study of Participants Who ReceivedAllogeneic CAR T-Cell Product
Recruiting
- Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
-
Culver City, CaliforniaScience 37, Inc.
Apr 10, 2023